MedTrace Logo

Effect of Breakfast or Omission of Breakfast in T2D

NCT01571310 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-10-11

No results posted yet for this study

Summary

The investigators will explore the effect of omission of breakfast on postprandial hyperglycemia and insulin and intact GLP-1 response after subsequent meals in type 2 diabetic patients

Conditions

Interventions

OTHER

Omitted Breakfast

Experimental:The patients in Omitted Breakfast day will omit the breakfast and will continue the overnight fast until lunch. They will eat only lunch (700 kcal) at 13:30 and dinner (700 kcal) at 19:00

OTHER

Breakfast

In the Active Comparator: The patients in the Breakfast day will consume breakfast (700 kcal) at 8:00 , lunch (700 kcal) at 13:30 and dinner (700 kcal) at 19:00 (YesB): The patients in YesB will eat all three mealswill consume three meals:

Sponsors & Collaborators

  • Hospital de Clinicas Caracas

    collaborator OTHER

  • Tel Aviv University

    lead OTHER

Principal Investigators

  • Julio Wainstein, MD · Head of Diabetes Unit E. Wolfson Medical Center Israel

  • Daniela Jakubowicz, MD · Hospital de Clinicas Caracas, Venezuela

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2016-04-30
Completion
2016-05-31

Countries

  • Israel
  • Venezuela

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01571310 on ClinicalTrials.gov